Concepedia

Jyothis T. George

JT

79

Publications

8K

Citations

43

H-Index

2007

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

University of Toronto

Lunenfeld-Tanenbaum Research Institute

Mount Sinai Hospital

Boehringer Ingelheim (Norway)

Jyothis T. George is an author at Boehringer Ingelheim (Germany) specializing in medicine, cardiovascular disease, and diabetes.

ORCID

Top concepts

Publications per year

2007–2023

79

Publications

79

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk

Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen et al. · JAMA · 2018 · 1K citations · Full text

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

Silvio E. Inzucchi, Bernard Zinman, David Fitchett et al. · Diabetes Care · 2017 · 721 citations

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes

Julio Rosenstock, Steven E. Kahn, Odd Erik Johansen et al. · JAMA · 2019 · 578 citations · Full text

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

Christoph Wanner, John M. Lachin, Silvio E. Inzucchi et al. · Circulation · 2017 · 462 citations · Full text

Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial

David Fitchett, Silvio E. Inzucchi, Christopher P. Cannon et al. · Circulation · 2019 · 342 citations · Full text

Rows per page

1–5 of 79